How is infliximab harmful?

Comment

Daniel G Arkfeld. Ann Intern Med. 2008.

. 2008 Jan 15;148(2):166; author reply 166.

doi: 10.7326/0003-4819-148-2-200801150-00014.

No abstract available

Comment on

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU; Infliximab-GCA Study Group. Hoffman GS, et al. Ann Intern Med. 2007 May 1;146(9):621-30. doi: 10.7326/0003-4819-146-9-200705010-00004. Ann Intern Med. 2007. PMID: 17470830 Clinical Trial.
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG. Salvarani C, et al. Ann Intern Med. 2007 May 1;146(9):631-9. doi: 10.7326/0003-4819-146-9-200705010-00005. Ann Intern Med. 2007. PMID: 17470831 Clinical Trial.